(1) This Policy has been developed within a framework established by the University's Immunisation Guidelines and the Code Of Practice - Work Integrated Learning (Professional Experience). (2) The Policy identifies the measures that students in the University of Wollongong (UOW) MBBS/MD degree program are required to take in order to minimise the risk of acquiring a blood-borne disease (BBV) or transmitting such a disease to patients/clients in the course of their placement. It also outlines the responsibilities of the Graduate School of Medicine and of medical students who may be infected with a BBV. (3) The Policy has been prepared in recognition that it is only part of the strategy to prevent the transmission of blood-borne infection in health care settings and should be viewed in line with wider strategies that support good infection control. (4) Whilst it is recognized that there is a low risk of transmission of blood-borne infections from medical practitioners to patients (RACP submission 2011), the purpose of this Policy is to protect the health of students and the patients/clients they encounter during a placement. The Graduate School of Medicine is committed to the importance of patient safety as well as providing privacy and medical confidentiality. (5) Students in the MBBS/MD may interact with patients/clients at on-campus clinics or at off campus facilities including hospitals/health care facilities in New South Wales, hospitals/health care facilities in other Australian states and territories and overseas placements. Within Australia, students who are placed in public facilities are required to comply with the policies of the relevant State health department, keeping in mind that State and Federal immunisation and blood-borne virus requirements are subject to change. In addition, if placements are negotiated with students which fall outside New South Wales and Australian jurisdictions there may be other requirements to be met. The UOW will endeavour to notify students within a reasonable timeframe of changes or additions to placement requirements with which students must comply. (6) The UOW owes a duty of care towards its students to minimise the risk of contracting infectious diseases in the course of their studies. Just as importantly, the UOW and individual students also owe a duty of care to patients/clients with whom students interact to minimise the risk of their acquiring infectious diseases as a result of that interaction. (7) Health care workers have an ethical duty to take all reasonable steps to protect patients/clients with whom they interact from adverse outcomes including the acquisition of avoidable infectious diseases. (8) The confidentiality of students concerning all personal matters, including their infection status in relation to blood-borne viruses should be respected. (9) Students who are living with a blood-borne virus will not be subjected to any form of discrimination apart from lawful preclusion from participating in EPP. (10) Prior to the commencement of placements, all students are required to comply with the NSW Health Occupational Assessment, Screening and Vaccination Against Specified Infectious Diseases Policy Directive including: (11) In accordance with the NSW Health Occupational Assessment, Screening and Vaccination Against Specified Infectious Diseases Policy Directive, UOW recommends that students are vaccinated in accordance with the latest edition of the Australian Immunisation Handbook. (12) For information on diseases and vaccination procedures, students should refer to the Australian Immunisation Handbook and discuss any concerns with a medical practitioner. Prior to any vaccination, students should discuss vaccine contraindications with their medical practitioner. Contraindications to vaccinations are given in the latest edition of the Australian Immunisation Handbook. (13) Non-participation in the vaccination requirements may increase a student’s risk of contracting disease through exposure to infected patients/clients in the clinical setting, and could also lead to a facility refusing to accept a student for placement and prevention of a student from meeting required components of their MBBS/MD. (14) All students are required to be aware of their status regarding infection with the following organisms prior to their placement: (15) This means that students should be checked on an annual basis (i.e. have four blood tests during the course of their studies). (16) Whilst current legislation only refers to HBV, students who are aware of infection with HIV and HCV should arrange to meet with the Dean of Graduate Medicine or designate, who will provide guidance in designing appropriate adjustments to the student’s program. As soon as practicable after enrolment in the MBBS/MD and prior to their first placement, students have to complete the necessary paperwork required by NSW Health (see Section 4.5). (17) If subsequent testing indicates that a student has acquired any of the relevant infections whilst enrolled in the program, they should immediately refrain from undertaking EPP and seek urgent confidential advice from the Dean of Graduate Medicine or designate. (18) The Anti-Discrimination Act 1977 prohibits discrimination on the grounds of impairment (which includes the presence of blood-borne virus). Infected students are entitled to their BBV status being treated confidentiality (within the limits of the law) and receiving appropriate support. In the event that a student considers he/she has been unlawfully discriminated against, they will have recourse to the Review and Appeal of Academic Decisions Policy. (19) Students who are aware that they are living with a blood-borne virus may still be able to participate in a placement as regulated under the Code Of Practice - Work Integrated Learning (Professional Experience). However, they must not participate in EPP and like all HCW must strictly adhere to standard infection control precautions (as set out in the Australian National Guidelines for the Management of Health Care Workers known to be Infected with Blood-Borne Viruses, and the Guidelines for medical practitioners and medical students infected with blood-borne viruses). (20) Students who are HIV positive, HBV positive and HCV positive should double glove for all invasive procedures, including those which are not considered to be exposure prone (NSW Health: HIV, Hepatitis B or C- Health Care Workers Infected 2005); Double gloving is also recommended for all cases where gloving is routinely recommended (Society for Healthcare Epidemiology of America (SHEA) Guidelines 2010), and for all contact with mucous membranes and open wounds (21) Whilst it is not a requirement of the MBBS/MD that students must be involved in EPP, there is always the possibility that they may be called upon to undertake EPP throughout the course of their study. Where the student is asked to perform an EPP, the student is to Decline. If insisted upon then contact the Dean of Graduate Medicine immediately on the number provided. (22) Students with a BBV must not: (23) Students with a BBV should not: (24) Students with a BBV may: (25) Students with a BBV have a reasonable expectation of confidentiality. Only those directly involved in the student’s supervision should be informed of their BBV status. In addition, the Graduate School of Medicine is required to take all reasonable steps to provide an environment in which students with a BBV are protected from unlawful discrimination and the effects of stigma in relation to their infection. All students are entitled to be treated with respect without prejudicing their capacity to improve in their course of study. Students or prospective students are not required to disclose their infection status for HIV or HCV to the UOW. They are, however, strongly encouraged to confidentially discuss their status with the Dean of Graduate Medicine, so that they can be assisted to consider how their training and future practice may need to be modified to ensure that patients/clients are not put at risk (26) Students are required to notify the Dean of Graduate Medicine if they have a current HBV infection. This information will be kept in confidence (so far as the law allows) in secure storage. Many clinical institutions to which students are placed have a mandatory requirement for hepatitis B immunisation and confidential negotiation with the institution will be required for any placements of a HBV student. (27) Should a student living with a BBV fail to follow the guidelines as established for managing EPP, there may be serious consequences. These include limitations on the capacity to undertake placement activities under the Code Of Practice - Work Integrated Learning (Professional Experience), potential action for misconduct under the Student Conduct Rules and/or adverse action for contravention of the Medical Board of Australia’s Mandatory Notification Policy. (28) Students in the MBBS/MD who have been exposed to BBV (through an occupational exposure or through unprotected sexual intercourse or unsafe injecting practice with a partner whose infection status is not definitively known) have an ethical responsibility to arrange further blood-borne virus testing at an appropriate interval after any exposure. They must refrain from participating in exposure prone procedures until they have been definitively determined not to be infected. (29) All students are required to read and comply with the infection control guidelines issued by the health department in each State in which they undertake placements. (30) Students are also required to participate in any infection control training provided by Graduate School of Medicine from time to time. (31) Exposure to blood or other body substances may occur from: (32) Adherence to standard infection control guidelines remains the first line of protection for health care workers against occupational exposure to blood borne viruses. Once an injury has occurred it is important to follow an accepted protocol and medical regimes as found in: (33) After exposure to blood or other body substances, the health care worker should as soon as possible do the following: (34) All injuries are to be reported to an immediate placement supervisor and: (35) The Graduate School of Medicine will inform students, prior to a placement and where relevant, of the need to be aware of their immunisation and BBV status. They will also notify students within a reasonable timeframe of changes or additions to requirements with which students must comply. Screening for infections and administration of vaccines and other medical treatment is not the direct responsibility of the Graduate School of Medicine, but it is responsible for collecting/sighting documentation from the student of compliance where required. (36) Subject to the law, the Graduate School of Medicine is responsible for ensuring that no BBV information regarding a student is disclosed to any person contrary to this procedure without the student’s express consent. Students who are infected with a BBV have the same rights of confidentiality as other patients (see Medical Board of Australia 2011, Guidelines for medical practitioners and medical students infected with blood-borne viruses). The Graduate School of Medicine may disclose BBV status to others within UOW only if necessary to perform its purposes. (37) The Graduate School of Medicine is required to take all reasonable steps to provide an environment in which students who are living with a BBV are protected from unlawful discrimination and the effects of stigma in relation to their infection. (38) The Head of Students will meet with the relevant Phase Chairs to map out the student’s individualised program during the MBBS/MD. Depending on the Phase, this will involve an initial discussion with the student and a range of relevant personnel associated with the Phase. These may include the Graduate School of Medicine clinical skills program coordinator; academic leaders, and GP Practice Principals; and Preceptors. Any clarification of the points raised in the discussion will be referred to the Dean of Graduate Medicine. (39) During Phases 3 and 4, under the Code Of Practice - Work Integrated Learning (Professional Experience) the Graduate School of Medicine will contact the placement facility to inform them of the student’s status. This will enable the Facility to clarify the major points from the procedures as well as provide adequate time to contact their insurers. (40) The Dean of Graduate Medicine and Head of Students will meet with the student to discuss what is meant by Invasive Procedures and EPPs and provide appropriate advice, support and referral (e.g. to an Infectious Disease Physician) for students in relation to immunisation and blood-borne viruses. Phase Chairs will also assist with the management of the student’s academic and clinical program throughout all phases of the MBBS/MD. (41) Patients, like HCWs, are best protected from exposure to BBV by adoption of appropriate infection control practices. In the absence of any significant exposure to blood or other body substances, patients are at an extremely low risk of acquiring blood-borne infections. It is not recommended that HCWs be required to disclose their BBV status to patients for the following reasons: (42) The UOW and the Graduate School of Medicine are committed to the safety of students and patients/clients. GM is required to actively promote measures to prevent or minimise the risk of transmission of infectious diseases including risk assessment of required activities, infection control practices/training, immunisations, serological and other testing of immunity and student access to health and safety documents/programs within facilities. (43) Henderson, D., Dembry, L., Fishman, N., Grady, C., Lundstrom, T., Palmore, T., Sepkowitz, K., Weber, D. (2010). SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infection Control and Hospital Epidemiology. March, 31 (3), 203-232.Policy for Managing Blood-Borne Viruses
Section 1 - Purpose of the Policy
Section 2 - Policy Principles
Duty of Care
Ethical Responsibilities
Confidentiality
Discrimination
Section 3 - Student Responsibilities
Enrolment Requirements
Vaccination
Testing for Blood-borne Viruses
Students who are Living with a Blood-borne Virus
Students who Develop a BBV During their Course
Compliance with State Government and University Infection Control Guidelines
Management of Exposure to Blood or Body Substances
Top of PageSection 4 - Graduate School of Medicine (GSM) Responsibilities
Ensuring Student Compliance
Protecting Student Confidentiality
Protecting Students from Harassment and Discrimination
Providing Advice, Support and Referral
Informing Patients of a Medical Student’s Health Status
Workplace Health and Safety: Preventing the Transmission of Infectious Diseases
Other References
Section 5 - Definitions
Top of Page
Section 6 - Appendix 1
SHEA Table 2: Categorization of Healthcare-Associated Procedures According to Level of Risk for Blood-borne Pathogen Transmission.
View Current
This is the current version of this document. You can provide feedback on this document to the document author - refer to the Status and Details on the document's navigation bar.
NB. For a detailed description of specific categories of procedures that are rated as minimal risk (Category 1) to those that are high risk (Category 3) go to Appendix I.
Word/Term
Definition (with examples if required)
Blood-Borne Viruses (BBV)
Identified as Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV).
Exposure Prone Procedure (EPP)
Procedures where there is a risk of injury to the health care worker (HCW) resulting in exposure of the patient’s open tissues to the blood of the HCW. These procedures include those where the HCW’s hands (whether gloved or not) may be in contact with sharp instruments, needle tips or sharp tissues (spicules of bone or teeth) inside a patient’s open body cavity, wound or confined anatomical space, where the hands or fingertips may not be completely visible at all times.
Procedures which lack these characteristics are unlikely to pose a risk of transmission of BBV from infected HCW to patients.
Provided they are not conducted in poorly visualised or confined body sites, the following procedures are not considered to be exposure prone - oral, vaginal or rectal examinations that do not involve sharp instruments; phlebotomy on adults; administering intramuscular, intradermal or subcutaneous injections; needle biopsies; needle aspirations; lumbar punctures; venous cutdown and angiographic procedures; excision of epidermal or dermal lesions; suturing of superficial skin lacerations; endoscopy; placing and maintaining peripheral and central intravascular lines, nasogastric tubes, rectal tubes and urinary catheters; acupuncture; other procedures that do not involve sharps; or procedures where the use of sharps is superficial, well visualised, and administered to compliant or anaesthetised patients where it is very unlikely that a HCW skin injury would result in exposure of a patient to the HCW’s blood or body substances.
For more information, please see the Australian National Guidelines for the Management of Health Care Workers known to be Infected with Blood-Borne Viruses.
Facility
A health or human service facility including a public health facility, public sector hospital or department, a private healthcare facility, community based health service or other facility or service run by a Health Service District or organisation or a University teaching clinic where a placement is undertaken.
GSM
Graduate School of Medicine at the University of Wollongong.
HBV
Hepatitis B virus.
HCV
Hepatitis C virus.
HCW
Health care worker – meaning persons, including students and trainees, whose activities involve direct contact with patients or with blood or body fluids from patients.
HIV
Human immunodeficiency virus.
Invasive procedure
Any procedure that pierces the skin or mucous membrane or enters a body cavity or organ. This includes surgical entry into tissues, cavities or organs or repair of traumatic injuries. EPP form a subset of invasive procedures.
For more information, please see NSW Health 2005, ‘HIV, Hepatitis B or Hepatitis C - Health Care Workers Infected’.
MBBS
Bachelor of Medicine Bachelor of Surgery degree course offered by the University through the Faculty of Science, Medicine and Health.
MD
Doctor of Medicine.
Placement
A practical educational experience, a required component of a course or degree program, in a health or human services facility that may be on-campus or off-campus. It is also known as professional practice, work-placement, work experience, work-integrated learning placement, fieldwork, practicum, internship, clinical experience, integrated clinical experience (ICE) or practical work.
A placement may fall within one of the following categories: Clinical placement; Service-orientated placement; Community placement; Organisational placement; Laboratory placement; Research placement; Environmental health placement. Placements may be outside of the Wollongong metropolitan area, other rural areas of NSW (10 Hubs) in other States or overseas.
Students
Medical students enrolled in the MBBS/MD at the University of Wollongong.
UOW
University of Wollongong.
Category I: Procedures with minimal risk of blood-borne virus transmission
Category II: Procedures for which blood-borne virus transmission is theoretically possible but unlikely
Category III: Procedures for which there is definite risk of blood-borne virus transmission or that have been classified previously as “exposure-prone”